Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of fructose-1 6-diphosphate as an inotrope drug after cardiopulmonary bypass surgery

Use of fructose-1 6-diphosphate as an inotrope drug after cardiopulmonary bypass surgery

US Patent 5944020 · Granted Aug 31, 1999

Estimated economic value: $659,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Mechanical assemblies for a treadmill2025
Treatment of sickle cell anemia crises with fructose-1,6-diphosphate as an analg2001
Treatment of sickle cell anemia crises with fructose-1,6-diphosphate as an analg2001
Treatment of sickle cell anemia crises with fructose-1,6-diphosphate as an analg2001
Medical use of fluorenone derivatives for treating and preventing brain and spin2001
Injection of fructose-1,6-diphosphate (FDP) prior to coronary artery bypass graf2000
Injection of fructose-1,6-diphosphate (FDP) prior to coronary artery bypass graf2000
Treatment of sickle cell anemia crises with fructose-1, 6-diphosphate as an anal2000
Treatment of sickle cell anemia crises with fructose-1, 6-diphosphate as an anal2000
Treatment of sickle cell anemia crises with fructose-1, 6-diphosphate as an anal2000
Neuroprotective poly-guanidino compounds which block presynaptic N and P/Q calci2000
Method of reducing pulmonary hypertension and atrial fibrillation after surgery 2000